Drug intelligence / Profile preview

FID 115958D

Development stage: Unknown
Modality: Hydrogel Systems → Drug Delivery Systems
Administration: Ophthalmic

Overview

FID 115958D is an investigational lubricant eye gel developed for the management of dry eye symptoms. It is formulated to provide long-lasting relief from dryness and irritation on the ocular surface, likely through a mechanism similar to other artificial tear preparations that coat and stabilize the tear film. The clinical evaluation of FID 115958D has focused on its effectiveness in alleviating signs and symptoms of dry eye, with outcome measures including frequency and severity of dry eye symptoms, tear film break-up time, ocular surface staining, and visual acuity[1][3].

Beyond the preview

Go deeper on FID 115958D.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FID 115958D.

Explore the full profile